Population pharmacokinetics of ripretinib in patients with advanced malignancies.

George, S; Janku, F; Chi, P; von Mehren, M; Somaiah, N; Gelderblom, H; Jones, RL; Allard, M; Taylor, A; Li, XY; Meade, J; Reichert, V; Ruiz-Soto, R; Wang, J; Heinrich, MC

CANCER RESEARCH, 2021; 81 (13):